Short Arrestin-3-Derived Peptides Activate JNK3 in Cells

Int J Mol Sci. 2022 Aug 4;23(15):8679. doi: 10.3390/ijms23158679.

Abstract

Arrestins were first discovered as suppressors of G protein-mediated signaling by G protein-coupled receptors. It was later demonstrated that arrestins also initiate several signaling branches, including mitogen-activated protein kinase cascades. Arrestin-3-dependent activation of the JNK family can be recapitulated with peptide fragments, which are monofunctional elements distilled from this multi-functional arrestin protein. Here, we use maltose-binding protein fusions of arrestin-3-derived peptides to identify arrestin elements that bind kinases of the ASK1-MKK4/7-JNK3 cascade and the shortest peptide facilitating JNK signaling. We identified a 16-residue arrestin-3-derived peptide expressed as a Venus fusion that leads to activation of JNK3α2 in cells. The strength of the binding to the kinases does not correlate with peptide activity. The ASK1-MKK4/7-JNK3 cascade has been implicated in neuronal apoptosis. While inhibitors of MAP kinases exist, short peptides are the first small molecule tools that can activate MAP kinases.

Keywords: JNK; arrestin-3; scaffold; short peptides.

MeSH terms

  • Arrestin* / metabolism
  • Arrestins / metabolism
  • Mitogen-Activated Protein Kinase 10* / metabolism
  • Peptides / metabolism
  • Peptides / pharmacology
  • Phosphorylation / physiology
  • Protein Binding / physiology
  • beta-Arrestin 2 / metabolism
  • beta-Arrestins / metabolism

Substances

  • Arrestin
  • Arrestins
  • Peptides
  • beta-Arrestin 2
  • beta-Arrestins
  • Mitogen-Activated Protein Kinase 10